Bright Minds Biosciences, Inc. (DRUG)
66.91
+1.75
(+2.69%)
USD |
NASDAQ |
Sep 08, 16:00
67.50
+0.59
(+0.88%)
Pre-Market: 08:05
Bright Minds Biosciences Price to Book Value : 3.042 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.042 |
| September 04, 2026 | 2.963 |
| September 03, 2026 | 3.093 |
| September 02, 2026 | 3.234 |
| September 01, 2026 | 3.221 |
| August 31, 2026 | 3.261 |
| August 28, 2026 | 3.310 |
| August 27, 2026 | 3.389 |
| August 26, 2026 | 3.484 |
| August 25, 2026 | 3.614 |
| August 24, 2026 | 3.502 |
| August 21, 2026 | 3.520 |
| August 20, 2026 | 3.572 |
| August 19, 2026 | 3.853 |
| August 18, 2026 | 3.821 |
| August 17, 2026 | 3.614 |
| August 14, 2026 | 3.476 |
| August 13, 2026 | 3.546 |
| August 12, 2026 | 3.609 |
| August 11, 2026 | 3.649 |
| August 10, 2026 | 3.673 |
| August 07, 2026 | 3.607 |
| August 06, 2026 | 3.674 |
| August 05, 2026 | 3.637 |
| August 04, 2026 | 3.517 |
| Date | Value |
|---|---|
| August 03, 2026 | 3.355 |
| July 31, 2026 | 3.331 |
| July 30, 2026 | 3.393 |
| July 29, 2026 | 3.231 |
| July 28, 2026 | 3.272 |
| July 27, 2026 | 3.270 |
| July 24, 2026 | 3.243 |
| July 23, 2026 | 3.241 |
| July 22, 2026 | 3.431 |
| July 21, 2026 | 3.514 |
| July 20, 2026 | 3.392 |
| July 17, 2026 | 3.461 |
| July 16, 2026 | 3.375 |
| July 15, 2026 | 3.452 |
| July 14, 2026 | 3.366 |
| July 13, 2026 | 3.452 |
| July 10, 2026 | 3.539 |
| July 09, 2026 | 3.556 |
| July 08, 2026 | 3.177 |
| July 07, 2026 | 2.939 |
| July 06, 2026 | 3.030 |
| July 02, 2026 | 3.074 |
| July 01, 2026 | 3.025 |
| June 30, 2026 | 3.192 |
| June 29, 2026 | 3.070 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.19 |
| Anika Therapeutics, Inc. | 2.051 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.715 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2671 |
| Price | 66.91 |
| Earnings Yield | -3.12% |
| Market Cap | 660.01M |
| PEGY Ratio | -0.2671 |